Evidence map›Paper›PMID 42418410›Full record

ArticlePLOS digital health2026

Large language models enable prognostic stratification of cancer patients using real-world clinical notes.

Niklas Kiermeyer, Tim Lenfers, Amin Dada, Julian Friedrich, Sameh Khattab, Eric Knop, Jan Egger, Markus Pauly, Andreas Jung, Grégoire Montavon and 10 more

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Niklas KiermeyerGerman Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
Tim LenfersInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.ORCID https://orcid.org/0009-0009-0960-2802
Amin DadaInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Julian FriedrichInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Sameh KhattabInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Eric KnopDepartment of Statistics, TU Dortmund University, Dortmund, Germany.
Jan EggerInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Markus PaulyDepartment of Statistics, TU Dortmund University, Dortmund, Germany.
Andreas JungInstitute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.
Grégoire MontavonBIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.
Jens T SivekeDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.ORCID https://orcid.org/0000-0002-8772-4778
Marcel WieswegDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Stefan KasperDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Ulf P NeumannDepartment of General, Visceral, Vascular and Transplantation Surgery, University Hospital Essen, Essen, Germany.
Frederick KlauschenGerman Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
Sylvia HartmannInstitute of Pathology, University Hospital Essen, Essen, Germany.
Martin SchulerDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Philipp KeylInstitute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.
Jens KleesiekInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Julius KeylInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.ORCID https://orcid.org/0000-0002-5617-091X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In medical documentation, vast amounts of unstructured text are generated that are still underutilized in current prognostic models. We investigate the potential of self-hosted large language models (LLM) to extract clinically meaningful, patient-specific information from routine clinical notes for personalized risk stratification in cancer care. We collected real-world medical notes from 2,708 non-small cell lung cancer (NSCLC) patients and 814 colon cancer patients documented before treatment at a large comprehensive cancer center. LLMs extracted key prognostic indicators, including comorbidities, metastatic sites, and qualitative descriptors of patient condition, in a zero-shot manner without prior task-specific training. Integrating these LLM-derived features into machine learning models significantly improved the prediction of overall survival compared to TNM staging alone (C-Index: NSCLC, 0.72 vs 0.64; colon cancer, 0.70 vs 0.59), and surpassed models using text embeddings. Based on the LLM-informed risk scores, patients were stratified into four distinct risk groups, enabling reclassification of 61.4% of NSCLC and 68.3% of colon cancer patients. Analysis of model drivers revealed that LLM-derived factors, such as the physical condition, substantially modulated the prognostic impact of TNM stage. These findings highlight the potential of self-hosted LLM to derive prognostically relevant information from unstructured clinical documentation and support clinical decision-making.

Identifiers

PMID42418410
PMCPMC13345263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.